Spring is officially here, and with it, daylight saving time (DST). The official position of the American Academy of Sleep Medicine is to eliminate DST and replace it with a permanent standardized time to support sleep health, and in this video, sleep expert Dr. Anne Marie Morse elucidates how DST affects our sleep cycles and why our bodies may feel different while adjusting to this change.
Advertisement
PGK1 antibody levels in patients with recovered immuno-related pancytopenia were negatively correlated with platelet levels.
Freely Filtered returns with another episode for NephMadness, this time, covering the hemodialysis region.
The Freely Filtered Filtrate discusses the top nephrology stories of 2024, including FLOW, cyberattacks, and IgAN trials.
Researchers estimated tuberculosis incidence and described the disease among the US population with kidney failure.
A study has uncovered a novel method to enhance immunotherapy for melanoma by targeting a protein known as MARCO.
Researchers assessed ICD gene expressions to predict immunotherapy response and immune cell infiltration.
A study examined whether kidney function decline accelerated after COVID-19 versus other respiratory infections.
Thrombosis history was not predictive of overall survival in patients with pulmonary hypertension risk and PV, a study found.
DocWire Content Partners
Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.
Fundamentals, core concepts, and important management approaches in the field of hematology and oncology
Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.
Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.
Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.
Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.
Powered by DocWire News
The Latest From GI Oncology Now
Suvemcitug, envafolimab, and FOLFIRI may serve as a new second-line treatment option for cold tumors.
KRASG12C inhibitors can have reduced efficacy in patients with alterations in KRAS, EGFR, and other genes.
Complete responders with HCC have prolonged survival and durable disease control even after therapy has been discontinued.
The primary objective of median PFS was significantly longer for patients treated with 177Lu-edotreotide.
The safety profile of the combination was consistent with known profiles, and no new safety findings were observed.
Older patients in their 70s with extrahepatic CCA have a higher rate of choledocholithiasis.
The Latest From Heme Today
PGK1 antibody levels in patients with recovered immuno-related pancytopenia were negatively correlated with platelet levels.
Thrombosis history was not predictive of overall survival in patients with pulmonary hypertension risk and PV, a study found.
The oral agent exhibited promising hemoglobin response performance and safety in this stage of an ongoing phase 2/3 study.
The first-in-class agent operates by increasing both von Willebrand factor and factor VIII levels in patients.
Immune thrombocytopenia featured most prominently at the Meeting but new data was presented for several forms of the disease.
Imetelstat is indicated for patients with lower-risk MDS who had an unsatisfactory response to or are ineligible to ESAs.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.